[go: up one dir, main page]

FR2368958A1 - Substances isolees de gonaderma lucidum (fr.) karst et leur application en therapeutique - Google Patents

Substances isolees de gonaderma lucidum (fr.) karst et leur application en therapeutique

Info

Publication number
FR2368958A1
FR2368958A1 FR7732743A FR7732743A FR2368958A1 FR 2368958 A1 FR2368958 A1 FR 2368958A1 FR 7732743 A FR7732743 A FR 7732743A FR 7732743 A FR7732743 A FR 7732743A FR 2368958 A1 FR2368958 A1 FR 2368958A1
Authority
FR
France
Prior art keywords
gonaderma
karst
lucidum
therapeutics
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7732743A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2368958A1 publication Critical patent/FR2368958A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

L'invention a pour objet trois substances nouvelles extraites de Gonaderma lucium (Fr.) Karst et un procédé d'isolement de ces substances. La première substance appelée <<A>> est active pour le traitement des maladies hépatiques; la seconde substance << B >> possède une activité anti-tumorale par administration orale; et la troisième substance <<C>> a un effet anti-inflammatoire.
FR7732743A 1976-10-30 1977-10-28 Substances isolees de gonaderma lucidum (fr.) karst et leur application en therapeutique Withdrawn FR2368958A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13074176A JPS5366412A (en) 1976-10-30 1976-10-30 Extracting and separating effective component of mushroom *1mannentake1*

Publications (1)

Publication Number Publication Date
FR2368958A1 true FR2368958A1 (fr) 1978-05-26

Family

ID=15041508

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7732743A Withdrawn FR2368958A1 (fr) 1976-10-30 1977-10-28 Substances isolees de gonaderma lucidum (fr.) karst et leur application en therapeutique

Country Status (6)

Country Link
US (1) US4145415A (fr)
JP (1) JPS5366412A (fr)
CA (1) CA1083137A (fr)
DE (1) DE2748259A1 (fr)
FR (1) FR2368958A1 (fr)
GB (1) GB1543849A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0591603A2 (fr) * 1992-10-06 1994-04-13 Toyo Seiyaku Kabushiki Kaisha Agent antimicrobien contre staphylococcus contenant un extrait de Ganoderma Lucidum

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5547624A (en) * 1978-09-29 1980-04-04 Chiyokichi Iizuka Remedy for hepatitis and its preparation
JPS60181026A (ja) * 1984-02-28 1985-09-14 Toyo Yakushiyoku Kogyo Kk 血糖降下剤
JPS61130235A (ja) * 1984-11-28 1986-06-18 Sunstar Inc 感染症治療薬
JPS61195669A (ja) * 1985-02-22 1986-08-29 Osaka Chem Lab 霊芝を原料とする健康食品
JP2808009B2 (ja) * 1989-03-14 1998-10-08 株式会社霊芝総合研究所 霊芝類の処理法
US5721134A (en) * 1990-12-04 1998-02-24 Il-Yang Pharmaceutical Co., Ltd. Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) having effect of antitumor immunity
JP2711201B2 (ja) * 1992-10-06 1998-02-10 東洋製薬株式会社 連鎖球菌抗菌剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
TW591105B (en) 1998-04-30 2004-06-11 Korea Inst Sci & Tech Novel immuno-stimulating polysaccharide substance from Phellinus spp. strain and use thereof
KR20010082721A (ko) 2000-02-18 2001-08-30 고니시 진우에몬 지방산 함유 조성물
US20030095981A1 (en) * 2001-05-30 2003-05-22 Kin-Ping Wong Compositions containing an active fraction isolated from ganoderma lucidum and methods of use
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
CN103977042A (zh) * 2014-05-15 2014-08-13 济南康众医药科技开发有限公司 冷冻技术在树舌干燥中的应用
EP3965796A4 (fr) * 2019-05-10 2022-07-06 Mayo Foundation for Medical Education and Research Procédés et matériaux pour le traitement de maladies cardiovasculaires

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070133A1 (fr) * 1969-10-15 1971-09-10 Kureha Chemical Ind Co Ltd
DD126818A1 (fr) * 1976-07-30 1977-08-17

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070133A1 (fr) * 1969-10-15 1971-09-10 Kureha Chemical Ind Co Ltd
DD126818A1 (fr) * 1976-07-30 1977-08-17

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1977 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0591603A2 (fr) * 1992-10-06 1994-04-13 Toyo Seiyaku Kabushiki Kaisha Agent antimicrobien contre staphylococcus contenant un extrait de Ganoderma Lucidum
EP0591603A3 (fr) * 1992-10-06 1994-11-23 Toyo Pharma Kk Agent antimicrobien contre staphylococcus contenant un extrait de Ganoderma Lucidum.
US5595742A (en) * 1992-10-06 1997-01-21 Toyo Seiyaku Kabushiki Kaisha Antimicrobial agent for staphylococcus

Also Published As

Publication number Publication date
CA1083137A (fr) 1980-08-05
GB1543849A (en) 1979-04-11
DE2748259A1 (de) 1978-05-03
JPS5366412A (en) 1978-06-13
US4145415A (en) 1979-03-20

Similar Documents

Publication Publication Date Title
FR2368958A1 (fr) Substances isolees de gonaderma lucidum (fr.) karst et leur application en therapeutique
NL990002I1 (nl) Rechtsdraaiend enenantiomeer van alfa (4,5,6,7-tetrahydrothienoÄ3,2-cÄ007fÜ-pyrid-5-yl)(2-chloorfenyl) methylacetaat, werkwijze voor de bereiding daarvan en deze bevattende farmaceutische preparaten.
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l&#39;hyperplasie de la prostate
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
NL189898C (nl) Vaste, farmaceutische doseringsvorm voor de orale toediening alsmede werkwijze ter vervaardiging daarvan.
BE855409A (fr) Compositions pharmaceutiques contenant un extrait purifie de racines de ginseng et procede de preparation d&#39;un tel extrait
FR2348201A1 (fr) Nouveaux medicaments pour le traitement des affections vasculaires ischemiques
FR2512670B1 (fr) Capsules contenant le principe actif d&#39;un allergene et procede pour leur preparation
FR2321892A1 (fr) Preparations pharmaceutiques pour l&#39;administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l&#39;hypertrophie benigne de la prostate
BE854416A (fr) Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d&#39;utilisation
NL7614538A (nl) Werkwijze ter bereiding van farmacologisch actieve heterocyclische verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
NL183462C (nl) Werkwijze voor het extraheren van werkzame verbindingen van het plasminogeen-type uit placentaire brij en werkwijze voor het bereiden van farmaceutische preparaten met toepassing van aldus geextraheerde verbindingen.
NL188948C (nl) Werkwijze ter bereiding van pyrido(1,2a)pyrimidines met werking tegen ontstekingen en tegen bloedstolling en werkwijze voor de bereiding van farmaceuttische preparaten die deze bevatten.
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l&#39;hypercholesterolemie
BE773121A (fr) Preparations pharmaceutiques destinees au traitement des hyperlipidemies et leur procede d&#39;obtention
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
FR2310769A1 (fr) Medicament pour le traitement de l&#39;alopecia seborrhoeica
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l&#39;hypertension
PT66817B (fr) Procede d&#39;extraction de dosage et d&#39;apport de produit
FR2374044A1 (fr) Agent anti-diabetique oral contenant une sulfonyluree et une kinine
BE856006A (fr) Nouveaux medicaments pour le traitement des surcharges lipidiques et de la cellulite
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la &#34; debrycine &#34; heterocolloidale et procede pour leur preparation
FR2325729A1 (fr) Installation pour le traitement sous vide d&#39;un produit, notamment pour l&#39;evaporation sous vide

Legal Events

Date Code Title Description
ST Notification of lapse